|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02563 BIOSTAR PHARM-B
Nominal 
8.000 -0.100 (-1.235%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (102,719) | (150,778) | (79,438) |
| Net Cash from / (used in) Investing Activities | 54,198 | 131,275 | (146,788) |
| Net Cash from / (used in) Financing Activities | 201,519 | (1,130) | 3,533 |
| Increase / (Decrease) in Cash & Cash Equivalents | 152,998 | (20,633) | (222,693) |
| Cash & Cash Equivalents at beginning of period | 38,087 | 60,106 | 268,415 |
| Effect of Foreign Exchange Rate Changes | (1,371) | (1,386) | 14,384 |
| Others | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 189,714 | 38,087 | 60,106 |
| Remarks: | Real time quote last updated: 11/08/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -143,776 |
| %Change | -24.186% |
| EPS / (LPS) | RMB -0.410 |
| NBV Per Share (¥) | RMB 2.169 |